Skip to main content
Erschienen in: International Journal of Colorectal Disease 6/2007

01.06.2007 | Original Article

Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition

verfasst von: S. Banerjee, N. Akbar, J. Moorhead, J. A. Rennie, A. J. M. Leather, D. Cooper, S. Papagrigoriadis

Erschienen in: International Journal of Colorectal Disease | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Serotonin is an important neuroendocrine transmitter participating in the control of colonic motor activity through neural and biochemical mechanisms in the Enteric Nervous System (ENS). A possible pathophysiological factor for diverticular disease (DD) is altered colonic motility. The study compared the distribution of serotonin cells (SC) in the colonic mucosa of patients with diverticular disease to controls.

Methods

Sixteen paraffin specimens with sigmoid diverticular disease were selected and sections of bowel without diverticula from the same specimen were used as its own control. The resection margins from sixteen colonic specimens excised for sigmoid cancer were additional controls. Immunocytochemical staining for serotonin cells was performed on 4-μm tissue sections with polyclonal antibody (NCL-SEROTp). The number of serotonin-positive cells per ten microscopic fields (×200) was assessed in all groups and the staining distribution was defined as low (0–33%), moderate (>33–66%) and high (>66%) according to the percentage of the entire cell containing contrast material. The control specimens were blinded before analysis. Student’s t test was used for statistical analysis and significance level was set as P < 0.05.

Results

The mean number of serotonin-positive cells per ten fields in the colonic mucosa of specimens with diverticular disease was significantly higher [252.44 (SD 90.64)] than the specimen’s own control [147.31 (SD 50.16)] and at normal resection margins of cancer specimens [228.38 (SD 120.10)]. The paired analysis between diverticular disease specimens and its own control (paired t test) showed significant differences for moderate (P = 0.008), high (P = 0.001) and total (P = 0.002) number of serotonin cells. There was no evidence of significance between mean DD and cancer values.

Discussion

Increased presence of SCs and the higher proportion of high and moderate staining cells (indicating increased hormone content) indicate the possible role of serotonin in DD. This may be contributing to the pathogenesis of the condition by altered colonic motility in the affected segments in a similar way as in irritable bowel syndrome.
Literatur
1.
Zurück zum Zitat Gershon MD, Sherman DL (1987) Noradrenergic innervation of serotoninergic neurons in the myenteric plexus. J Comp Neurol 259:193–210PubMedCrossRef Gershon MD, Sherman DL (1987) Noradrenergic innervation of serotoninergic neurons in the myenteric plexus. J Comp Neurol 259:193–210PubMedCrossRef
2.
Zurück zum Zitat Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M (1993) Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 266:74–80PubMed Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M (1993) Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 266:74–80PubMed
3.
Zurück zum Zitat Potela-Gomes GM, Stridsberg M, Johansson H, Grimelius L (1997) Complex co-location of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem 45:815–822 Potela-Gomes GM, Stridsberg M, Johansson H, Grimelius L (1997) Complex co-location of chromogranins and neurohormones in the human gastrointestinal tract. J Histochem Cytochem 45:815–822
4.
Zurück zum Zitat Cetin Y, Muller-Koppel L, Aunis D, Bader MF, Grube D (1989) Chromogranin A (CgA) in the gastro–enteric–pancreatic (GEP) endocrine system. II. CgA in mammalian entero-endocrine cells. Histochemistry 92:265–275PubMedCrossRef Cetin Y, Muller-Koppel L, Aunis D, Bader MF, Grube D (1989) Chromogranin A (CgA) in the gastro–enteric–pancreatic (GEP) endocrine system. II. CgA in mammalian entero-endocrine cells. Histochemistry 92:265–275PubMedCrossRef
5.
Zurück zum Zitat Sjolund K, Sanden G, Hakanson R, Sundler F (1983) Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85:1120–1130PubMed Sjolund K, Sanden G, Hakanson R, Sundler F (1983) Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85:1120–1130PubMed
6.
Zurück zum Zitat Meyer T, Brinck U (1999) Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract. Digestion 60:63–68PubMedCrossRef Meyer T, Brinck U (1999) Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract. Digestion 60:63–68PubMedCrossRef
7.
Zurück zum Zitat Wade PR, Westfall JA (1985) Ultrastructure of enterochromaffin cells and associated neural and vascular elements in the mouse duodenum. Cell Tissue Res 241:557–563PubMedCrossRef Wade PR, Westfall JA (1985) Ultrastructure of enterochromaffin cells and associated neural and vascular elements in the mouse duodenum. Cell Tissue Res 241:557–563PubMedCrossRef
8.
Zurück zum Zitat Iversen L (2000) Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry 5:357–362PubMedCrossRef Iversen L (2000) Neurotransmitter transporters: fruitful targets for CNS drug discovery. Mol Psychiatry 5:357–362PubMedCrossRef
9.
Zurück zum Zitat Fuller RW, Wong DT (1990) Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 600:68–80PubMedCrossRef Fuller RW, Wong DT (1990) Serotonin uptake and serotonin uptake inhibition. Ann N Y Acad Sci 600:68–80PubMedCrossRef
10.
Zurück zum Zitat Blakely RD, Berson HE, Fremeau RT et al (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66–70PubMedCrossRef Blakely RD, Berson HE, Fremeau RT et al (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66–70PubMedCrossRef
11.
Zurück zum Zitat Ramamoothy S, Bauman AL, Moore KR et al (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90:2542–2546CrossRef Ramamoothy S, Bauman AL, Moore KR et al (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A 90:2542–2546CrossRef
12.
Zurück zum Zitat Hoffman B, Mezey E, Brownstein M (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254:579–580PubMedCrossRef Hoffman B, Mezey E, Brownstein M (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254:579–580PubMedCrossRef
13.
Zurück zum Zitat Kim DY, Camilleri M (2000) Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 95:2698–2709PubMed Kim DY, Camilleri M (2000) Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 95:2698–2709PubMed
14.
Zurück zum Zitat Bouras EP, Camilleri M, Burton DD, McKinzie S (1999) Selective stimulation of colonic transit by the benzfuran 5-HT4 agonist, prucalopride, in the healthy humans. Gut 44:682–686PubMedCrossRef Bouras EP, Camilleri M, Burton DD, McKinzie S (1999) Selective stimulation of colonic transit by the benzfuran 5-HT4 agonist, prucalopride, in the healthy humans. Gut 44:682–686PubMedCrossRef
15.
Zurück zum Zitat Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M (1993) Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 266:74–80PubMed Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M (1993) Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 266:74–80PubMed
16.
Zurück zum Zitat Kishibayashi N, Miwa Y, Hayashi H et al (1993) 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome. J Med Chem 36:3286–3292PubMedCrossRef Kishibayashi N, Miwa Y, Hayashi H et al (1993) 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome. J Med Chem 36:3286–3292PubMedCrossRef
17.
Zurück zum Zitat Talley NJ, Phillips SF, Haddad A et al (1990) GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 35:477–480PubMedCrossRef Talley NJ, Phillips SF, Haddad A et al (1990) GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 35:477–480PubMedCrossRef
18.
Zurück zum Zitat Gershon MD (1999) Review article: roles played by 5-hydroxytryptamine in the physiology of bowel. Aliment Pharmacol Ther 13:15–30PubMedCrossRef Gershon MD (1999) Review article: roles played by 5-hydroxytryptamine in the physiology of bowel. Aliment Pharmacol Ther 13:15–30PubMedCrossRef
19.
Zurück zum Zitat Sarna SK (1991) Physiology and pathophysiology of colonic motor activity. Dig Dis Sci 36:827–862PubMedCrossRef Sarna SK (1991) Physiology and pathophysiology of colonic motor activity. Dig Dis Sci 36:827–862PubMedCrossRef
20.
Zurück zum Zitat Zhao RH, Baig MK, Thaler KJ, Mack J, Abramson S, Woodhouse S, Tamir H, Wexner SD (2003) Reduced expression of serotonin receptor(s) in the left colon of patients with colonic inertia. Dis Colon Rectum 46(1)81–86, (January)PubMedCrossRef Zhao RH, Baig MK, Thaler KJ, Mack J, Abramson S, Woodhouse S, Tamir H, Wexner SD (2003) Reduced expression of serotonin receptor(s) in the left colon of patients with colonic inertia. Dis Colon Rectum 46(1)81–86, (January)PubMedCrossRef
21.
Zurück zum Zitat Zhao R, Baig MK, Wexner SD, Chen W, Singh JJ, Nogueras JJ, Woodhouse S (2000) Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia. Dis Colon Rectum 43:858–863PubMedCrossRef Zhao R, Baig MK, Wexner SD, Chen W, Singh JJ, Nogueras JJ, Woodhouse S (2000) Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia. Dis Colon Rectum 43:858–863PubMedCrossRef
22.
Zurück zum Zitat Hughes LE (1969) Postmortem survey of diverticular disease of the colon. 1. Diverticulosis and diverticulitis. Gut 10:336–344PubMed Hughes LE (1969) Postmortem survey of diverticular disease of the colon. 1. Diverticulosis and diverticulitis. Gut 10:336–344PubMed
23.
Zurück zum Zitat American Gastroenterological Association (2001) The burden of gastrointestinal diseases. American Gastroenterological Association, Bethesda American Gastroenterological Association (2001) The burden of gastrointestinal diseases. American Gastroenterological Association, Bethesda
24.
Zurück zum Zitat Simpson J, Scholefield JH, Spiller RC (2003) Origin of symptoms in diverticular disease. Br J Surg 90(8):899–908, (August)PubMedCrossRef Simpson J, Scholefield JH, Spiller RC (2003) Origin of symptoms in diverticular disease. Br J Surg 90(8):899–908, (August)PubMedCrossRef
25.
Zurück zum Zitat Painter NS, Burkitt DP (1975) Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 4:53–69 Painter NS, Burkitt DP (1975) Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 4:53–69
26.
Zurück zum Zitat Weinreich J, Andersen D (1976) Intraluminal pressure in the sigmoid colon. II. Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 11:581–586PubMed Weinreich J, Andersen D (1976) Intraluminal pressure in the sigmoid colon. II. Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 11:581–586PubMed
27.
Zurück zum Zitat Eastwood MA, Smith AN, Brydon WG, Pritchard J (1978) Colonic function in patients with diverticular disease. Lancet 1:1181–1182PubMedCrossRef Eastwood MA, Smith AN, Brydon WG, Pritchard J (1978) Colonic function in patients with diverticular disease. Lancet 1:1181–1182PubMedCrossRef
28.
Zurück zum Zitat Viebig RG, Pontes JF, Michelsohn NH (1994) Electromanometry of the rectosigmoid colon in colonic diverticulosis. Arq Gastroenterol 31:135–144PubMed Viebig RG, Pontes JF, Michelsohn NH (1994) Electromanometry of the rectosigmoid colon in colonic diverticulosis. Arq Gastroenterol 31:135–144PubMed
29.
Zurück zum Zitat Suchowiecky M, Clarke DD, Bhasker M, Perry RJ, Snape WJ (1987) Effect of secoverine on colonic myoelectric activity in diverticular disease. Dig Dis Sci 32:833–840PubMedCrossRef Suchowiecky M, Clarke DD, Bhasker M, Perry RJ, Snape WJ (1987) Effect of secoverine on colonic myoelectric activity in diverticular disease. Dig Dis Sci 32:833–840PubMedCrossRef
30.
Zurück zum Zitat Trotman IF, Misiewicz JJ (1988) Sigmoid motility in diverticular disease and the irritable bowel syndrome. Gut 29:218–222PubMed Trotman IF, Misiewicz JJ (1988) Sigmoid motility in diverticular disease and the irritable bowel syndrome. Gut 29:218–222PubMed
31.
Zurück zum Zitat Cortesini C, Pantalone D (1991) Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease. Dis Colon Rectum 34:339–342PubMedCrossRef Cortesini C, Pantalone D (1991) Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease. Dis Colon Rectum 34:339–342PubMedCrossRef
32.
Zurück zum Zitat Painter NS, Truelove SC (1964) The intraluminal pressure patterns in diverticulosis of the colon. Gut 5:365–369PubMed Painter NS, Truelove SC (1964) The intraluminal pressure patterns in diverticulosis of the colon. Gut 5:365–369PubMed
33.
Zurück zum Zitat Arfwidsson S (1964) Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand 342(Suppl):1–68 Arfwidsson S (1964) Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand 342(Suppl):1–68
34.
Zurück zum Zitat Bassotti G, Battaglia E, Spinozzi F, Pelli MA, Tonini M (2001)Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity. Dis Colon Rectum 44(12):1814–1820 (December)PubMedCrossRef Bassotti G, Battaglia E, Spinozzi F, Pelli MA, Tonini M (2001)Twenty-four hour recordings of colonic motility in patients with diverticular disease: evidence for abnormal motility and propulsive activity. Dis Colon Rectum 44(12):1814–1820 (December)PubMedCrossRef
35.
Zurück zum Zitat Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123:2108–2131PubMedCrossRef Drossman DA, Camilleri M, Mayer EA, Whitehead WE (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123:2108–2131PubMedCrossRef
36.
Zurück zum Zitat Richardson BP, Engel G, Donatscg P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131PubMedCrossRef Richardson BP, Engel G, Donatscg P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131PubMedCrossRef
37.
Zurück zum Zitat Bearcroft CP, Perrett D, Farthing MJG (1998) Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 42:42–46PubMedCrossRef Bearcroft CP, Perrett D, Farthing MJG (1998) Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 42:42–46PubMedCrossRef
38.
Zurück zum Zitat El-Salhy M, Norrgard O, Spinnell S (1999) Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 34:1007–1011PubMedCrossRef El-Salhy M, Norrgard O, Spinnell S (1999) Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol 34:1007–1011PubMedCrossRef
39.
Zurück zum Zitat Kyosola K, Penttila O, Salaspuro M (1977) Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 12:363–367PubMedCrossRef Kyosola K, Penttila O, Salaspuro M (1977) Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 12:363–367PubMedCrossRef
40.
Zurück zum Zitat Lumsden K, Chaudhary NA, Truelove SC (1963) The irritable colon syndrome. Clin Radiol 14:54–63PubMedCrossRef Lumsden K, Chaudhary NA, Truelove SC (1963) The irritable colon syndrome. Clin Radiol 14:54–63PubMedCrossRef
41.
42.
Zurück zum Zitat Havia T, Manner R (1971) The irritable colon syndrome. A follow-up study with special reference to the development of diverticula. Acta Chir Scand 137:569–572PubMed Havia T, Manner R (1971) The irritable colon syndrome. A follow-up study with special reference to the development of diverticula. Acta Chir Scand 137:569–572PubMed
43.
Zurück zum Zitat Parks TG (1969) Natural history of diverticular disease of the colon. A review of 521 cases. BMJ 4:639–642PubMed Parks TG (1969) Natural history of diverticular disease of the colon. A review of 521 cases. BMJ 4:639–642PubMed
44.
Zurück zum Zitat Zollinger RW (1968) The prognosis in diverticulitis of the colon. Arch Surg 97:418–422PubMed Zollinger RW (1968) The prognosis in diverticulitis of the colon. Arch Surg 97:418–422PubMed
45.
Zurück zum Zitat Segal I, Walker AR (1984) The irritable bowel syndrome in the black community. S Afr Med J 65:72–73PubMed Segal I, Walker AR (1984) The irritable bowel syndrome in the black community. S Afr Med J 65:72–73PubMed
46.
Zurück zum Zitat Painter NS, Burkitt DP (1971) Diverticular disease of the colon: a deficiency disease of Western civilization. BMJ 2:450–454PubMedCrossRef Painter NS, Burkitt DP (1971) Diverticular disease of the colon: a deficiency disease of Western civilization. BMJ 2:450–454PubMedCrossRef
47.
Zurück zum Zitat Katschinski M, Lederer P, Ellermann A, Ganzleben R, Lux G, Arnold R (1990) Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis. Scand J Gastroenterol 25:761–768PubMed Katschinski M, Lederer P, Ellermann A, Ganzleben R, Lux G, Arnold R (1990) Myoelectric and manometric patterns of human rectosigmoid colon in irritable bowel syndrome and diverticulosis. Scand J Gastroenterol 25:761–768PubMed
48.
Zurück zum Zitat Hyland JM, Darby CF, Hammond P, Taylor I (1980) Myoelectrical activity of the sigmoid colon in patients with diverticular disease and the irritable colon syndrome suffering from diarrhoea. Digestion 20:293–299PubMedCrossRef Hyland JM, Darby CF, Hammond P, Taylor I (1980) Myoelectrical activity of the sigmoid colon in patients with diverticular disease and the irritable colon syndrome suffering from diarrhoea. Digestion 20:293–299PubMedCrossRef
49.
Zurück zum Zitat Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43–II47PubMedCrossRef Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA (1999) Functional bowel disorders and functional abdominal pain. Gut 45(Suppl 2):II43–II47PubMedCrossRef
50.
Zurück zum Zitat Narducci F, Bassotti G, Gaburri M, Morelli A (1987) Twenty-four hour manometric recording of colonic motor activity in healthy man. Gut 28:17–25PubMed Narducci F, Bassotti G, Gaburri M, Morelli A (1987) Twenty-four hour manometric recording of colonic motor activity in healthy man. Gut 28:17–25PubMed
51.
Zurück zum Zitat Coates MD, Mahoney CR, Linden DR et al (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and IBS. Gastroenterology 126:1657–1664PubMedCrossRef Coates MD, Mahoney CR, Linden DR et al (2004) Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and IBS. Gastroenterology 126:1657–1664PubMedCrossRef
52.
Zurück zum Zitat Wade PR, Chen J, Jaffe B et al (1996) Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16:2352–2364PubMed Wade PR, Chen J, Jaffe B et al (1996) Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 16:2352–2364PubMed
53.
Zurück zum Zitat Chen J-X, Pan H, Rothman TP et al (1998) Guinea pig 5-HT transporter: cloning, expression, distribution and function in intestinal sensory reception. Am J Physiol 275:G433–G448PubMed Chen J-X, Pan H, Rothman TP et al (1998) Guinea pig 5-HT transporter: cloning, expression, distribution and function in intestinal sensory reception. Am J Physiol 275:G433–G448PubMed
54.
Zurück zum Zitat Chen JJ, Zhishan L, Pan H et al (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters. J Neurosci 21:6348–6361PubMed Chen JJ, Zhishan L, Pan H et al (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters. J Neurosci 21:6348–6361PubMed
55.
Zurück zum Zitat Linden DR, Chen JX, Gershon MD et al (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285:G207–G216PubMed Linden DR, Chen JX, Gershon MD et al (2003) Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 285:G207–G216PubMed
56.
Zurück zum Zitat Gershon MD (2005) Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol. The Spectrum of Functional Gastrointestinal Disorders (FGID) 39(5) Supplement 3:S184–S193 (May/June) Gershon MD (2005) Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol. The Spectrum of Functional Gastrointestinal Disorders (FGID) 39(5) Supplement 3:S184–S193 (May/June)
57.
Zurück zum Zitat Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA (2005) The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 26(9):1513–1519 (Sep)PubMedCrossRef Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA (2005) The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 26(9):1513–1519 (Sep)PubMedCrossRef
58.
Zurück zum Zitat Samoha S, Arber N (2005) Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology 69(Suppl 1):33–37PubMedCrossRef Samoha S, Arber N (2005) Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side. Oncology 69(Suppl 1):33–37PubMedCrossRef
59.
Zurück zum Zitat Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2001) Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 49(3):402–408 (Sep)PubMedCrossRef Tibble J, Sigthorsson G, Foster R, Sherwood R, Fagerhol M, Bjarnason I (2001) Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut 49(3):402–408 (Sep)PubMedCrossRef
Metadaten
Titel
Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition
verfasst von
S. Banerjee
N. Akbar
J. Moorhead
J. A. Rennie
A. J. M. Leather
D. Cooper
S. Papagrigoriadis
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 6/2007
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-006-0216-4

Weitere Artikel der Ausgabe 6/2007

International Journal of Colorectal Disease 6/2007 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.